Analysis of clinical trials of new drugs in China as of 2019-Reference-Cited by-同舟云学术

Analysis of clinical trials of new drugs in China as of 2019

Published:2020-12 Issue:12 Volume:25 Page:2080-2088
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Lin Longfei,Chen Yiren,Yan Lei,Liu Yuling,Ni Jian,Yang Hongjun,Li Hui

Funder

Fundamental Research Funds

Young Elite Scientists Sponsorship Program

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference37 articles.

1. Challenges in anticancer drug R&D in China;Zhao;Lancet Oncol.,2019

2. Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review;Li;Lancet Oncol.,2019

3. Announcement of the State Food and Drug Administration on the Information Platform for Drug Clinical Studies;China Food and Drug Administration,2013

4. Clinical trials and drug approvals continue to accelerate in China;Wang;Lancet Oncol.,2017

5. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study;Lin;J. Hematol. Oncol.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers;Drug Design, Development and Therapy;2024-06

2. Sociodemographic characteristics of healthy volunteers along with their experience, attitude and concerns of clinical trials in Wuhan, China;Scientific Reports;2023-11-09

3. Antibacterial drugs and cyclodextrin inclusion complexes: a patent review;Expert Opinion on Drug Delivery;2023-02-15

4. Impact of the COVID-19 pandemic on clinical trials: a cross-sectional questionnaire study in China;Annals of Translational Medicine;2022-11

5. Analysis of Clinical Trials of New Drugs for Liver Diseases in China;Drug Design, Development and Therapy;2021-07